Acurx Pharmaceuticals, Inc.
ACXP· Nasdaq
ACXPAcurx Pharmaceuticals, Inc.
Filed May 12, 2023 · 10-Q · 42 days after period end · 0001558370-23-009495
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$2.90M | -$2.67M | -$1.47M | -$1.28M |
| EPS Diluted | -$0.25 | -$0.26 | -$0.21 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acurx Pharmaceuticals, Inc. · CIK 1736243 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 12, 2023 · 42 d after period end
